Sfoglia per Autore
Trasforming growth factor-beta1 inhibits the proliferation of rat astrocytes induced by serum and growth factors
1995 Vergelli M., Mazzanti B., Ballerini C., Gran B., Amaducci L. and Massacesi L.
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients.
1998 A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats.
1999 A.M. PAPINI; S. MAZZUCCO; D. PINZANI; M. BIONDI; M. CHELLI; M. GINANNESCHI; G. RAPI; B. MAZZANTI; M. VERGELLI; L. MASSACESI; L. AMADUCCI
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases
1999 Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells.
2000 MAZZANTI B.; HEMMER B.; TRAGGIAI E.; BALLERINI C.; MCFARLAND H.F.; MASSACESI L.; MARTIN R.; VERGELLI M.;
EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS
2001 A.M. PAPINI; E. NARDI; B. MAZZANTI; T. BIAGIOLI; C. BALLERINI; E. TRAGGIAI; M. CHELLI; M. GINANNESCHI; H. KALBACHER; M. DEEG; L. MASSACESI; M. VERGELLI
Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis.
2001 Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L;
IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J. Neuroimmunol.
2001 TRAGGIAI E; BIAGIOLI T; ROSATI E; BALLERINI C; MAZZANTI B; BEN NUN A; MASSACESI L; VERGELLI M;
Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS.
2002 MURARO P.A; BONANNI L; MAZZANTI B; PANTALONE A; TRAGGIAI E; MASSACESI L; VERGELLI M; GAMBI D;
Towards a therapeutic apheresis in multiple sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies
2003 Peroni, E; Lolli, F; Mazzanti, B; Pazzagli, M; Bonetti, B; Massacesi, L; Chelli, M; Rovero, P; Papini, AM.
Structure-activity relationship study of glycopeptide antigens recognizing specific autoantibodies in Multiple Sclerosis.
2003 B. Mulinacci; F. Nuti; G. Sabatino; M. Chelli; A. Carotenuto; P. Rovero; B. Mazzanti; M. Pazzagli; F. Lolli; A. M. Papini
Sugar–Scan of CSF114(Glc) for autoantibody recognition in autoimmune diseases.
2003 F. Nuti; I. Paolini; B. Mulinacci; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; F. Lolli; M. Chelli; F. Cordero; A. Brandi; A. M. Papini
MS PepKit, the first diagnostic test based on CSF114(Glc) a glycopeptide to follow-up Multiple Sclerosis.
2003 A.M. Papini, B. Mulinacci, E. Peroni, F. Nuti, G. Sabatino, M.C. Pozo-Carrero, B. Mazzanti, M. Pazzagli, L. Massacesi, M. Chelli, P. Rovero, F. Lolli
MS PepKit: the first diagnostic test based on CSF114(Glc), a glycopeptide to follow-up Multiple Sclerosis.
2003 A. M. Papini; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; M. Chelli; P. Rovero; F. Lolli
Towards a therapeutic apheresis in Multiple Sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies.
2003 E. Peroni; F. Lolli; B. Mazzanti; M. Pazzagli; B. Bonetti; L. Massacesi; M. Chelli; P. Rovero; A. M. Papini
Synthetic peptides in the diagnosis of neurological diseases
2003 F. LOLLI; B. MAZZANTI; P. ROVERO; A.M. PAPINI
An innovative approach to the synthesis of N-glycopeptides
2004 E. Peroni; F. Peri; F. Nuti; B. Mazzanti; M. Chelli; A.M. Papini
Optimisation of synthetic strategies to glycosylated amino acids
2004 I. Paolini; F. Nuti; B. Kolesinska; F. Cardona; M. Chelli; B.Mazzanti; F. Lolli; A. Brandi; A.M. Papini
Structure-Activity Relationship Study of Glycopeptide Antigens Recognizing Specific Autoantibodies in Multiple Sclerosis
2004 B. Mulinacci; F. Nuti; G. Sabatino; M. Chelli; A. Carotenuto; P. Rovero; B. Mazzanti; M. Pazzagli; F. Lolli; A.M. Papini
MS PepKit. The First Diagnostic Test to Follow-up Multiple Sclerosis
2004 A.M. Papini; B. Mulinacci; A. Carotenuto; B. Bonetti; G. Sabatino; E. Peroni; F. Nuti; M.C. Alcaro; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; L. Battistini; M. Chelli; P. Rovero; F. Lolli.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Trasforming growth factor-beta1 inhibits the proliferation of rat astrocytes induced by serum and growth factors | 1995 | Vergelli M., Mazzanti B., Ballerini C., Gran B., Amaducci L. and Massacesi L. | |
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. | 1998 | A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI | |
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats. | 1999 | A.M. PAPINI; S. MAZZUCCO; D. PINZANI; M. BIONDI; M. CHELLI; M. GINANNESCHI; G. RAPI; B. MAZZANTI; M. VERGELLI; L. MASSACESI; L. AMADUCCI | |
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases | 1999 | Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M | |
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. | 2000 | MAZZANTI B.; HEMMER B.; TRAGGIAI E.; BALLERINI C.; MCFARLAND H.F.; MASSACESI L.; MARTIN R.; VERGELLI M.; | |
EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS | 2001 | A.M. PAPINI; E. NARDI; B. MAZZANTI; T. BIAGIOLI; C. BALLERINI; E. TRAGGIAI; M. CHELLI; M. GINANNESCHI; H. KALBACHER; M. DEEG; L. MASSACESI; M. VERGELLI | |
Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis. | 2001 | Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L; | |
IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J. Neuroimmunol. | 2001 | TRAGGIAI E; BIAGIOLI T; ROSATI E; BALLERINI C; MAZZANTI B; BEN NUN A; MASSACESI L; VERGELLI M; | |
Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. | 2002 | MURARO P.A; BONANNI L; MAZZANTI B; PANTALONE A; TRAGGIAI E; MASSACESI L; VERGELLI M; GAMBI D; | |
Towards a therapeutic apheresis in multiple sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies | 2003 | Peroni, E; Lolli, F; Mazzanti, B; Pazzagli, M; Bonetti, B; Massacesi, L; Chelli, M; Rovero, P; Papini, AM. | |
Structure-activity relationship study of glycopeptide antigens recognizing specific autoantibodies in Multiple Sclerosis. | 2003 | B. Mulinacci; F. Nuti; G. Sabatino; M. Chelli; A. Carotenuto; P. Rovero; B. Mazzanti; M. Pazzagli; F. Lolli; A. M. Papini | |
Sugar–Scan of CSF114(Glc) for autoantibody recognition in autoimmune diseases. | 2003 | F. Nuti; I. Paolini; B. Mulinacci; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; F. Lolli; M. Chelli; F. Cordero; A. Brandi; A. M. Papini | |
MS PepKit, the first diagnostic test based on CSF114(Glc) a glycopeptide to follow-up Multiple Sclerosis. | 2003 | A.M. Papini, B. Mulinacci, E. Peroni, F. Nuti, G. Sabatino, M.C. Pozo-Carrero, B. Mazzanti, M. Pazzagli, L. Massacesi, M. Chelli, P. Rovero, F. Lolli | |
MS PepKit: the first diagnostic test based on CSF114(Glc), a glycopeptide to follow-up Multiple Sclerosis. | 2003 | A. M. Papini; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; M. Chelli; P. Rovero; F. Lolli | |
Towards a therapeutic apheresis in Multiple Sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies. | 2003 | E. Peroni; F. Lolli; B. Mazzanti; M. Pazzagli; B. Bonetti; L. Massacesi; M. Chelli; P. Rovero; A. M. Papini | |
Synthetic peptides in the diagnosis of neurological diseases | 2003 | F. LOLLI; B. MAZZANTI; P. ROVERO; A.M. PAPINI | |
An innovative approach to the synthesis of N-glycopeptides | 2004 | E. Peroni; F. Peri; F. Nuti; B. Mazzanti; M. Chelli; A.M. Papini | |
Optimisation of synthetic strategies to glycosylated amino acids | 2004 | I. Paolini; F. Nuti; B. Kolesinska; F. Cardona; M. Chelli; B.Mazzanti; F. Lolli; A. Brandi; A.M. Papini | |
Structure-Activity Relationship Study of Glycopeptide Antigens Recognizing Specific Autoantibodies in Multiple Sclerosis | 2004 | B. Mulinacci; F. Nuti; G. Sabatino; M. Chelli; A. Carotenuto; P. Rovero; B. Mazzanti; M. Pazzagli; F. Lolli; A.M. Papini | |
MS PepKit. The First Diagnostic Test to Follow-up Multiple Sclerosis | 2004 | A.M. Papini; B. Mulinacci; A. Carotenuto; B. Bonetti; G. Sabatino; E. Peroni; F. Nuti; M.C. Alcaro; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; L. Battistini; M. Chelli; P. Rovero; F. Lolli. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile